loading
reading
writing
saving
searching
QR Code Link to This Post
A clinical study is enrolling adults with type 1 diabetes and overweight to evaluate the impact of tirzepatide on digestion. One dose, up to a 5-night stay, and follow-up visits. Compensation up to $7,000 provided.
✅ Adults with overweight aged 18 - 70
✅ Between 25+
✅ Stable weight and no recent changes in diet or exercise
✅ Must be willing to stay at the clinic for up to 5 nights and attend follow-up visits